GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.ADMA Biologics Faces Short-Seller Allegations of Revenue Inflation
Law firm investigates $ADMA over channel stuffing claims. Stock plummets 16.63% after short report alleges actual 2025 revenues declined 3% despite reported 20% growth.
ADMAsecurities investigationstock price decline